These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
805 related articles for article (PubMed ID: 17707755)
21. Hypertension and cognitive function in the elderly. Cherubini A; Lowenthal DT; Paran E; Mecocci P; Williams LS; Senin U Am J Ther; 2007; 14(6):533-54. PubMed ID: 18090879 [TBL] [Abstract][Full Text] [Related]
23. Treating essential hypertension. The first choice is usually a thiazide diuretic. Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125 [TBL] [Abstract][Full Text] [Related]
24. Phenotypic characteristics of resistant hypertension in the Brazilian population. Faria AP; Sabbatini AR; Coca A; Moreno H Arq Bras Cardiol; 2013 Jun; 100(6):579-82. PubMed ID: 23657267 [TBL] [Abstract][Full Text] [Related]
25. Choice of antihypertensive drug in the diabetic patient. Ong HT; Cheah JS MedGenMed; 2005 May; 7(2):74. PubMed ID: 16369452 [TBL] [Abstract][Full Text] [Related]
26. [Blood pressure goal and choice of antihypertensive treatment in patients with mild hypertensive cardiovascular disease]. Narumi H; Takano H; Komuro I Nihon Rinsho; 2008 Aug; 66(8):1566-73. PubMed ID: 18700559 [TBL] [Abstract][Full Text] [Related]
27. [Success of blood pressure reduction in diabetic patients]. Schernthaner G Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S247-51. PubMed ID: 17139580 [TBL] [Abstract][Full Text] [Related]
28. The future of antihypertensive treatment. Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579 [TBL] [Abstract][Full Text] [Related]
29. Retrospective and prospective research on hypertension-related end-organ damage. Perloff D J Cardiovasc Pharmacol; 1994; 24 Suppl A():S1-5. PubMed ID: 7603071 [TBL] [Abstract][Full Text] [Related]
30. Hypertension strategies for therapeutic intervention and prevention of end-organ damage. Houston MC Prim Care; 1991 Sep; 18(3):713-53. PubMed ID: 1946795 [TBL] [Abstract][Full Text] [Related]
31. Systolic blood pressure and cardiovascular outcomes during treatment of hypertension. Weber MA; Bakris GL; Hester A; Weir MR; Hua TA; Zappe D; Dahlof B; Velazquez EJ; Pitt B; Jamerson K Am J Med; 2013 Jun; 126(6):501-8. PubMed ID: 23541376 [TBL] [Abstract][Full Text] [Related]
32. Office management of hypertension in older persons. Aronow WS Am J Med; 2011 Jun; 124(6):498-500. PubMed ID: 21605724 [TBL] [Abstract][Full Text] [Related]
33. [Cardiovascular risk stratification and therapeutic implications in arterial hypertension]. Handschin A; Henny-Fullin K; Buess D; Dieterle T Ther Umsch; 2015 Jun; 72(6):361-8. PubMed ID: 26098185 [TBL] [Abstract][Full Text] [Related]
34. [The best of hypertension 2005]. Chamontin B Arch Mal Coeur Vaiss; 2006 Jan; 99 Spec No 1(1):35-41. PubMed ID: 16479962 [TBL] [Abstract][Full Text] [Related]
35. [AII antagonists in the treatment of hypertension and prevention of CVA]. Spinar J; Vitovec J Vnitr Lek; 2013 Jan; 59(1):71-8. PubMed ID: 23565527 [TBL] [Abstract][Full Text] [Related]
36. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
37. Statins in hypertension: are they a new class of antihypertensive agents? Feldstein CA Am J Ther; 2010; 17(3):255-62. PubMed ID: 19918164 [TBL] [Abstract][Full Text] [Related]
38. Hypertension risk prediction: an important but complicated assessment. Lackland DT Hypertension; 2010 Jun; 55(6):1304-5. PubMed ID: 20439819 [No Abstract] [Full Text] [Related]